NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes

By sjmartinez • November 9, 2022

Calabrese DR, Tsao T, Magnen M, Valet C, Gao Y, Mallavia B, Tian JJ, Aminian EA, Wang KM, Shemesh A, Punzalan EB, Sarma A, Calfee CS, Christenson SA, Langelier CR, Hays SR, Golden JA, Leard LE, Kleinhenz ME, Kolaitis NA, Shah RJ, Venado A, Lanier LL, Greenland JR, Sayah DM, Ardehali A, Kukreja J, Weigt SS, Belperio JA, Singer JP, Looney MR. NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes. JCI Insight. 2022 Nov 8:e164603. doi: 10.1172/jci.insight.164603. Epub ahead of print. PMID: 36346670.

Tags: Cardiology/Epi, Immunology, Neutrophils, NK cells, Organ transplantation, Publications, Pulmonary, Critical Care & Sleep Medicine, Pulmonology

Medical Therapy Before, During, and After Hospitalization in Medicare Beneficiaries with Heart Failure and Diabetes: The Get With The Guidelines – Heart Failure Registry

Bhatt AS, Fonarow GC, Greene SJ, Holmes DN, Alhanti B, DeVore AD, Butler J, Heidenreich PA, Huang JC, Kittleson MM, Linganathan K, Joynt Maddox KE, ...

Development and Optimization of the Veterans Affairs’ National Heart Failure Dashboard for Population Health Management

Brownell N, Kay C, Parra D, Anderson S, Ballister B, Cave B, Conn J, Dev S, Kaiser S, Rogers J, Touloupas AD, Verbosky N, Yassa ...

Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management

Bhatt AS, Vaduganathan M, Claggett BL, Fonarow GC, Packer M, Pfeffer MA, Shah SJ, Shen X, Cristino J, McMurray JJV, Solomon SD, Gaziano TA. Health ...